Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)

Fig. 4

A, B Proliferation rates of ASPP2κ-interferenced RD and ssRMS cell strains vs empty vector (EV) controls. Statistical test: two-way ANOVA. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05 (C), (D) Computed growth rates in dependence of ASPP2κ expression. The assay was performed in 3 × technical triplicates

Back to article page